Have a feature idea you'd love to see implemented?
Let us know!
OSTX OS Therapies Inc
Price (delayed)
$1.857
Market cap
$39.44M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.95
Enterprise value
$37.58M
OS Therapies Incorporated is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. Our mission is to address
Highlights
OS Therapies's debt has plunged by 100% from the previous quarter and by 100% YoY
The equity has surged by 97% since the previous quarter and by 97% year-on-year
OS Therapies's net income has increased by 17% YoY but it has decreased by 14% from the previous quarter
Key stats
What are the main financial stats of OSTX
Market
Valuations
Earnings
Shares outstanding
21.24M
Market cap
$39.44M
Enterprise value
$37.58M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$5M
EBITDA
-$5M
Free cash flow
-$5.78M
Per share
Balance sheet
Liquidity
EPS
-$0.95
Free cash flow per share
-$0.36
Book value per share
-$0.03
Revenue per share
$0
TBVPS
$0.12
Total assets
$1.98M
Total liabilities
$2.68M
Debt
$0
Equity
-$707,127
Working capital
-$613,787
Debt to equity
0
Current ratio
0.76
Quick ratio
0.72
Net debt/EBITDA
0.37
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-574.4%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
N/A
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
OSTX stock price
How has the OS Therapies stock price performed over time
Intraday
7.64%
1 week
-15.59%
1 month
-37.89%
1 year
N/A
YTD
N/A
QTD
-33.68%
Financial performance
How have OS Therapies's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$5M
Net income
-$7.36M
Gross margin
N/A
Net margin
N/A
The operating income has plunged by 57% from the previous quarter
OS Therapies's net income has increased by 17% YoY but it has decreased by 14% from the previous quarter
Growth
What is OS Therapies's growth rate over time
Valuation
What is OS Therapies stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has increased by 45% year-on-year and by 17% since the previous quarter
The equity has surged by 97% since the previous quarter and by 97% year-on-year
Efficiency
How efficient is OS Therapies business performance
The ROA has soared by 58% YoY and by 16% from the previous quarter
Dividends
What is OSTX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for OSTX.
Financial health
How did OS Therapies financials performed over time
OS Therapies's total assets is 26% lower than its total liabilities
The total liabilities has plunged by 91% from the previous quarter and by 88% YoY
OS Therapies's total assets has increased by 47% QoQ
OS Therapies's debt is 100% more than its equity
OS Therapies's debt has plunged by 100% from the previous quarter and by 100% YoY
OS Therapies's debt to equity has soared by 100% from the previous quarter and by 100% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.